Cancer Patients Admitted to Nursing Homes: What Do We Know?

Journal of the American Medical Directors Association

Volumn 9, Issue 3, 2008, Pages 149-156

  Rodin, Miriam B ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANDROGEN; ANTHRACYCLINE; ANTIDEPRESSANT AGENT; ANTINEOPLASTIC AGENT; ANXIOLYTIC AGENT; APPETITE STIMULANT; AROMATASE INHIBITOR; BEVACIZUMAB; CAPECITABINE; CETUXIMAB; CYCLOPHOSPHAMIDE; DOXORUBICIN; ERLOTINIB; FLUOROURACIL; FUROSEMIDE; INTERFERON; MEGESTROL ACETATE; METHOTREXATE; METOCLOPRAMIDE; NEUROLEPTIC AGENT; PAMIDRONIC ACID; PREDNISONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RITUXIMAB; TAXANE DERIVATIVE; THALIDOMIDE; TRASTUZUMAB; VINCRISTINE;

ADVANCED CANCER; B CELL LYMPHOMA; BONE MARROW SUPPRESSION; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER PALLIATIVE THERAPY; CANCER PATIENT; CANCER REGISTRY; CANCER SURVIVAL; CANCER THERAPY; CARDIOTOXICITY; CLINICAL TRIAL; COORDINATION DISORDER; DELIRIUM; DEPRESSION; DERMATITIS; DIARRHEA; DISORDERS OF LIPID AND LIPOPROTEIN METABOLISM; DRUG SAFETY; DYSAUTONOMIA; FEBRILE NEUTROPENIA; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; HOME CARE; HOSPICE CARE; HUMAN; LONG TERM CARE; LUNG CANCER; MUCOSA INFLAMMATION; MULTIPLE MYELOMA; NAUSEA AND VOMITING; NEUROPATHY; NEUROTOXICITY; NONHODGKIN LYMPHOMA; NURSING HOME; OTOTOXICITY; OUTPATIENT CARE; PARESTHESIA; PREDICTION; PROBABILITY; PROGNOSIS; REHABILITATION CARE; RESOURCE MANAGEMENT; REVIEW; STROKE; TERMINAL CARE; WEAKNESS;

EID: 39149142198     PISSN: 15258610     EISSN: 15389375     Source Type: Journal    
DOI: 10.1016/j.jamda.2007.11.011     Document Type: Review

References (60)

1. National Cancer Institute, and United States National Institutes of Health. Cancer Trends Progress Report 2007 Update. http://progressreport.cancer.gov/trends-glance.asp. www.cancer.gov Accessed December 11, 2007
2. US estimated 28-year limited-duration prevalence on 1/1/2004 for all cancer sites. First malignancy cancer only by age group, race, sex and years since diagnosis. http://canques.seer.cancer.gov Accessed 31 Oct 2007
3. Van Dijk P.T.M., Mehr D.R., Ooms M.E., et al. Comorbidity and 1-year mortality risks in nursing home residents. J Am Geriatr Soc 53 (2005) 660-665
4. Teno J.M. Quality of care and quality indicators for end-of-life cancer care: hope for the best, yet prepare for the worst (2001), National Academy Press, Washington DC 96-131
5. Gallo W.T., Baker M.J., and Bradley E.H. Factors associated with home versus institutional death among cancer patients in Connecticut. J Am Geriatr Soc 49 (2001) 771-777
6. Johnson V., Teno J.M., Bourbonniere M., and Mor V. Palliative care needs of cancer patients in US nursing homes. J Palliative Med 8 (2005) 273-279
7. Buchanan R.J., Barkley J., Wang S., and Kim M.S. Analysis of nursing home residents with cancer at admission. Cancer Nurs 28 (2005) 406-414
8. McMillan A., Mentnech R.M., Lubitz J., McBean A.M., and Russell D. Trends and patterns in place of death for Medicare enrollees. Health Care Financ Rev 12 (1990) 1-7
9. Ferrell B.A. Care of cancer patients in nursing homes. Oncology 6 Suppl 2 (1992) 141-145
10. Seo P.H., Pieper C.F., and Cohen H.J. Effects of cancer history and comorbid conditions on mortality and healthcare use among older cancer survivors. Cancer 101 (2004) 2276-2284
11. Retchin S.M., Penberthy L., Desch C., Brown R., Jerome-Emilia B., and Clement B. Perioperative management of colon cancer under Medicare risk programs. Arch Internal Med 157 (1997) 1878-1884
12. Yabroff K.R., Davis W.W., Lamont E.B., et al. Patient time costs associated with cancer care. J Natl Cancer Inst 99 (2007) 14-23
13. Buchanan R.J., Barkley J., Wang S., and Kim M.S. Analysis of nursing home residents with cancer at admission. Cancer Nurs 28 (2005) 406-414
14. Mitchell S.L., KeIley D.K., and Hamel M.B. Dying with advanced dementia in the nursing home. Arch Intern Med 162 (2004) 321-326
15. Jordhoy M.S., Saltvedt I., Fayers P., Loge J.H., Ahlner-Elmqvist M., and Kaasa S. Which cancer patients die in nursing homes?. Quality of life, medical and sociodemographic characteristics. Palliative Med 17 (2003) 433-444
16. Repetto L., Venturino A., Vercelli M., et al. Performance status and comorbidity in elderly cancer patients compared with young patients with neoplasia and elderly patients without neoplastic conditions. Cancer 82 (1998) 760-765
17. Hurria A., Hurria A., Zuckerman E., et al. A prospective longitudinal study of the functional status and quality of life of older patients with breast cancer receiving adjuvant chemotherapy. J Am Geriatric Soc 54 (2006) 1119-1124
18. Mohile S.G., Bylow K., Dale W., et al. A pilot study of the Vulnerable Elders Survey-13 compared with the comprehensive geriatric assessment for identifying disability in older patients with prostate cancer who receive androgen ablation. Cancer 109 (2007) 802-810
19. Flood K.L., Carroll M.B., Le C.V., Ball L., Esker D.A., and Carr D.B. Geriatric syndromes in elderly patients admitted to an oncology acute care for elders unit. J Clin Orthod 24 (2006) 2298-2303
20. Koroukian S.M., Murray P., and Medigan E. Comorbidity, Disability and geriatric syndromes in elderly cancer patients receiving home health care. J Clin Orthod 24 (2006) 2304-2310
21. Beccaro M., Costantini M., Rossi P.G., et al. Actual and preferred place of death of cancer patients: results from the Italian survey of the dying of cancer (ISDOC). J Epidemiol Comm Health 60 (2006) 412-416
22. Davies E., Linklater K.M., Jack R.H., Clark L., and Moller H. How is place of death from cancer changing and what affects it?. Analysis of cancer registration and service data. Br J Cancer 95 (2006) 593-600
23. Gatrell A.C., Harman J.C., Francis B.J., Thomas C., Morris S.M., and McIllmurray M. Place of death: analysis of cancer deaths in part of North West England. J Public Health Med 25 (2003) 53-58
24. Higginson I.J., Astin P., and Dolan S. Where do cancer patients die?. Ten-year trends in the place of death of cancer patients in England. Palliat Med 12 (1998) 353-363
25. Gomes B., and Higginson I.J. Factors affecting death at home in terminally ill patients with cancer: systematic review. Br Med J 332 (2006) 515-521
26. Leibovitz A., Habot B., Lobart E., Gil L., and Walach N. Skilled nursing facilities as a setting for comprehensive care of older people with advanced cancer: A model of care in the post oncologic stage. J Am Med Dir Assoc 1 (2000) 74-76
27. Christakis N.A., and Lamont E.B. Extent and determinants of error in doctors' prognosis in terminally ill patients: A prospective cohort study. BMJ 320 (2000) 469-472
28. Lamont E.B., and Christakis N.A. Complexities in prognostication in advanced cancer. JAMA 290 (2003) 98-104
29. Lamont E.B., and Christakis N.A. Prognostic disclosure in patients with cancer near the end of life. Arch Intern Med 134 (2001) 1096-1105
30. Brandt H.E., Deliens L., Ooms M.E., van der Steen J.T., van der Waal G., and Ribbe M.W. Symptoms, signs, problems and diseases of terminally ill nursing home patients. Arch Intern Med 165 (2005) 314-320
31. Teno J.M., Weitzen S., Fennell M.L., and Mor V. Dying trajectory in the last year of life: does cancer trajectory fit other diseases?. J Palliat Med 4 (2001) 457-464
32. Lunney J.R., Lynn J., Foley D.J., Lipson S., and Guralnik J.M. Patterns of functional decline at the end of life. JAMA 289 (2003) 2387-2392
33. Chen J.H., Chan D.C., Kiely D.K., Morris J.N., and Mitchell S.L. Terminal trajectories of functional decline in the long term care setting. J Gerontol A Biol Sci Med Sci 62A (2007) 531-536
34. Miller S.C., and Mor V. The emergence of Medicare hospice care in US nursing homes. Palliat Med 15 (2001) 471-480
35. Casarett D.J., Hirschman K.B., and Henry M.R. Does hospice have a role in nursing home care at the end of life?. J Am Geriatr Soc 49 (2001) 1493-1498
36. Buchanan R.J., Choi M., Wang S., and Huang C. Analysis of nursing home residents in hospice care using the Minimum Data Set. Palliat Med 16 (2002) 465-480
37. Bernabei R., Gambassi G., Lapane K., et al. Management of pain in elderly patients with cancer. JAMA 279 (1998) 1877-1882
38. Mor V., Papandonatos G., and Miller S.C. End of life hospitalization for African-American and non-Latino white nursing home residents: Variation by race and a facility's racial composition. J Palliat Med 8 (2005) 58-68
39. Trask P.C., Teno J.M., and Nash J. Transitions of care and changes in distressing pain. J Pain Symptom Manage 32 (2006) 104-109
40. Teno J.M., Kabumoto G., Wetle T., Roy J., and Mor V. Daily pain was excruciating at some time in the previous week: Prevalence, characteristics and outcomes in nursing home residents. J Am Geriatr Soc 52 (2004) 762-767
41. Sawyer P., Lillis P., Bodner E., and Allman R.M. Substantial daily pain among nursing home residents. J Am Med Dir Assoc 8 (2007) 158-165
42. Zerzan J., Stearns S., and Hanson L. Access to palliative care and hospice in nursing homes. JAMA 284 (2000) 2489-2494
43. Goodwin D.M., Higginson I.J., Edwards A.G., et al. An evaluation of systematic reviews of palliative care services. J Palliat Care 18 (2002) 77-83
44. Finlay I.G., Higginson I.J., Goodwin D.M., et al. Palliative care in hospital, hospice, at home: results from a systematic review. Ann Oncol 13 Suppl 4 (2002) 257-264
45. Higginson I.J., Finlay I., Goodwin D.M., et al. Do hospital-based palliative teams improve care for patients or families at the end of life?. J Pain Symptom Manage 23 (2002) 96-106
46. Hall P., Schroeder C., and Weaver L. The last 48 hours of life in long-term care: A focused chart audit. J Am Geriatr Soc 50 (2002) 501-506
47. Parker-Oliver D., Porock D., and Zweig S. End-of-life care in US nursing homes: A review of the evidence. J Am Med Dir Assoc 5 (2004) 147-155
48. Teno J.M., Clarridge B.R., Casey V., et al. Family perspectives on end-of-life care at the last place of care. JAMA 291 (2004) 88-93
49. Miller S.C., Mor V., and Teno J. Hospice enrollment and pain assessment and management in nursing homes. J Pain Symptom Manage 26 (2003) 791-799
50. Miller S.C., Intrator O., Gozalo P., Roy J., Barber J., and Mor V. Government expenditures at the end of life for short- and long-stay nursing home residents: Differences by hospice enrollment status. J Am Geriatr Soc 52 (2004) 1284-1292
51. Jordhoy M.S., Fayers P., Loge J.H., Ahlner-Elmqvist M., and Kaasa S. Quality of life in palliative cancer care: Results from a cluster randomized trial. J Clin Oncol 19 (2001) 3884-3894
52. Coleman E.A., and Berenson R.A. Lost in transition: Challenges and opportunities for improving the quality of transitional care. Ann Intern Med 141 (2004) 533-536
53. Moore C., McGinn T., and Halm E. Tying up loose ends: Discharging patients with unresolved medical issues. Arch Intern Med 167 (2007) 1305-1311
54. Boockvar K., Fishman E., Kyriacou C.K., Monias A., Gavi S., and Cortes T. Adverse events due to discontinuations in drug use and dose changes in patients transferred between acute and long term care facilities. Arch Intern Med 164 (2004) 545-550
55. Kimmick G. Chemotherapy/Pharmacology. In: Kennedy BJ, eds. ASCO Curriculum. Cancer care in the older population. ASCO, Alexandria, VA.
56. Musselman D.L., Lawson D.H., Gumnick J.F., et al. Paroxetine for the prevention of depression induced by high dose interferon-Alfa. N Engl J Med 344 (2001) 961-966
57. Maccabee J. The effect of transfer from a palliative care unit to nursing homes: Are patients' and relatives' needs met?. Palliat Med 8 (1994) 211-214
58. Bookvar K.S., and Burack O.R. Organizational relationships between nursing homes and hospitals and quality of care during hospital-nursing home patient transfers. J Am Geriatr Soc 55 (2007) 1078-1084
59. Ghusn H.F., Teasdale T.A., and Jordan D. Continuity of do not resuscitate orders between hospital and nursing home settings. J Am Geriatr Soc 45 (1997) 465-469
60. Yeh S.S., Lovitt S., and Schuster M.W. Pharmacological treatment of geriatric cachexia: Evidence and safety in perspective. J Am Med Dir Assoc 8 (2007) 363-377